Skip to content

    Investment Firms in St. Louis, Missouri, United States

    An emerging venture capital hub, its ecosystem is anchored by significant strengths in biotech, life sciences, and healthcare, largely driven by major research universities and medical institutions. The investment landscape is characterized by a focus on early to growth-stage funding, supporting a pipeline of innovation from its academic core. This has fostered a collaborative and research-intensive startup environment distinct from larger coastal markets.

    St. Louis, Missouri, United States's investment landscape is shaped by Biotech & Life Sciences, with 71% of its 7 investment firms focused on this sector. The most active by portfolio size are Ascension Ventures, iSelect Fund, and Ascend Venture Capital.

    Biotech & Life Sciences dominates the investment landscape in St. Louis, with 71% of investment firms focused on this sector.

    St. Louis has a long history of venture capital, with Centene operating since 1984.

    Last updated: 28 April 2026

    Investment Firms

    7

    Total Investments

    95

    Top Sector

    Biotech & Life Sciences

    Top Stage

    Series A

    Top Investment Sectors in St. Louis

    The most popular sector focus among St. Louis investment firms is Biotech & Life Sciences, with 5 investment firms (71%) investing in the space. This is followed by Healthcare (4), Fintech (2), AI (2), Food & Agriculture (2).

    Investment Stages in St. Louis

    St. Louis investment firms are most active at the Series A stage (4 investment firms). This is followed by Series B (4), Seed (2), Pre-Seed (1), Series D (1).

    Frequently Asked Questions

    International